Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia

Published:2010-10-20 Issue:1 Volume:66 Page:175-179
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Kvitko C. H.,Rigatto M. H.,Moro A. L.,Zavascki A. P.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/66/1/175/2144395/dkq390.pdf

Reference13 articles.

1. Nosocomial bloodstream infections due to metallo- -lactamase-producing Pseudomonas aeruginosa

2. Multidrug-resistantPseudomonas aeruginosaandAcinetobacter baumannii: resistance mechanisms and implications for therapy

3. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review

4. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria

5. Effectiveness and safety of colistin: prospective comparative cohort study

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety Factors Related to Plasma Concentration-Optimized Polymyxin B Therapy in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in China;Infection and Drug Resistance;2024-07

2. Efficiency of polymyxin B treatment against nosocomial infection: a systematic review and meta-analysis;Frontiers in Medicine;2024-05-28

3. Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects;Antimicrobial Agents and Chemotherapy;2024-04-22

4. Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae;Frontiers in Pharmacology;2022-12-16

5. Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling;Pharmaceuticals;2022-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3